Sexual Health, STIs, and GU Onco… PNLE Questions
Introduction
This live inventory contains exactly 13 original PNLE-style practice questions, last updated August 12, 2026. It belongs to NP4, Medical-Surgical, and is a practice resource rather than an actual, recalled, or leaked board-question set.
Sexual Health, STIs, and GU Oncology covers STI clinical management, genital cancers, and sexual-function nursing in adult disease. The decisions include recognizing lesion and symptom patterns, selecting the appropriate diagnostic direction, identifying complications that need escalation, supporting prescribed treatment and partner management, and assessing how disease or treatment affects sexual function, body image, and fertility concerns.
Under the 2025 Enhanced TOS, this topic is a Tangerine pedagogical lens mapped across relevant competencies in the official five-subject PNLE TOS, not a separate official test subject. The official TOS does not provide a guaranteed microtopic weight, so this inventory should guide practice without predicting how many questions will appear on an exam form.
Key concepts
- Recognize possible pelvic inflammatory disease
Recognize: Lower abdominal or pelvic pain with abnormal discharge, fever, dyspareunia, or pelvic tenderness can indicate an ascending infection and requires focused assessment.
Decide: Assess severity, obtain ordered specimens, monitor for worsening findings, and promptly escalate care when systemic illness or severe pain is present.
Avoid: Waiting for one laboratory result before responding to a concerning clinical pattern. - Use lesion morphology as a clue, not a final diagnosis
Recognize: A painful vulvar blister or grouped vesicles suggest a different STI pattern from a painless, firm ulcer associated with primary syphilis.
Decide: Document location, pain, number, appearance, duration, and associated symptoms, then support the ordered confirmatory testing.
Avoid: Naming an organism from appearance alone or assuming every genital ulcer has the same cause. - Match the diagnostic direction to the suspected infection
Recognize: STI evaluation may require a site-specific specimen, molecular testing, culture, microscopy, or serology depending on the organism and presentation.
Decide: Verify the ordered specimen, collection site, timing, labeling, and follow-up plan before treatment or discharge teaching.
Avoid: Treating one negative test as proof that every STI has been excluded. - Complete treatment and address reinfection risk
Recognize: Persistent symptoms, missed doses, untreated partners, or resumed sexual contact contrary to clinical instructions can lead to ongoing infection or reinfection.
Decide: Reinforce the prescribed regimen, follow-up, symptom reporting, and evaluation or treatment of partners when indicated.
Avoid: Treating the index patient as the only person relevant to preventing recurrence. - Connect untreated infection with reproductive complications
Recognize: Recurrent or ascending infection can damage reproductive structures and may contribute to infertility, chronic pelvic pain, or other complications.
Decide: Assess pain and treatment response, explain the reason for follow-up, and refer fertility or persistent-symptom concerns through the care team.
Avoid: Reassuring a patient that resolved symptoms prove the infection caused no lasting harm. - Investigate genital and GU oncology warning signs
Recognize: A persistent ulcer, mass, unexplained bleeding, abnormal discharge, or urinary change needs evaluation rather than automatic attribution to an STI.
Decide: Record the finding accurately, assess related symptoms, support diagnostic referral, and monitor effects of treatment on comfort and function.
Avoid: Delaying evaluation because the patient is young, embarrassed, or has a prior infection history. - Assess sexual function as part of adult nursing care
Recognize: Disease, surgery, pain, medication effects, body-image changes, and cancer treatment may affect desire, arousal, erection, lubrication, orgasm, intimacy, or fertility concerns.
Decide: Ask privately and without assumptions, identify the patient’s goals, provide permitted education, and coordinate referral for persistent concerns.
Avoid: Equating sexual function with fertility or assuming that the topic is irrelevant during acute illness or oncology care.
What to expect on the PNLE
The live inventory supports several forms of nursing reasoning. Its representative content includes organism or syndrome recognition, lesion characteristics, incubation-period recall, diagnostic-test selection, PID recognition, gonorrhea management, partner treatment, infertility implications, and counseling after treatment. These forms require the learner to connect a cue with the safest next assessment, treatment-support action, follow-up need, or referral.
The difficulty distribution is easy=6, hard=5, medium=2, while the Bloom distribution is remembering=7, applying=4, understanding=2. Use that profile to prepare for both direct recall and short clinical decisions, but do not treat it as a prediction of any board examination.
- Remembering: Retrieve characteristic lesions, organism-related concepts, incubation information, and diagnostic directions accurately.
- Understanding: Explain why ascending infection can produce pelvic complications and why cancer or its treatment can alter sexual function.
- Applying: Prioritize assessment, treatment support, partner follow-up, safety teaching, or referral from the findings presented.
- Form selection: Read for the decisive cue, then compare options by urgency, completeness of care, and alignment with the ordered diagnostic or management plan.
Exact topic distribution varies by exam form. The official TOS supplies broad competency structure, so use these questions to build transferable decisions rather than to forecast a specific microtopic count.
Study tips
- Start with diagnostic practice. Complete the 13-question inventory without looking up answers, and mark each response as confident, uncertain, or guessed. This separates knowledge gaps from test-taking hesitation.
- Use focused retrieval by decision. Create prompts for STI clues, diagnostic directions, treatment and partner follow-up, PID complications, GU oncology red flags, and sexual-function assessment. Draw a five-column comparison table: condition | hallmark clue | test direction | immediate nursing action | complication or follow-up risk. Fill it from memory before checking notes.
- Review every rationale and error. For each missed or guessed item, write the cue you overlooked, the unsafe action you nearly chose, and the principle that supports the better decision. Separate recognition errors, such as confusing lesion patterns, from management errors, such as omitting follow-up or partner evaluation.
- Retry with spacing. Re-answer the missed items after a gap, then reconstruct the comparison table without seeing the original version. Include one short verbal explanation of why a negative or incomplete finding does not automatically exclude the suspected condition.
- Finish with mixed timed practice. Mix STI management, genital and GU oncology, sexual-function nursing, and the adjacent areas of Male Reproductive and Urologic Care and Infectious Diseases. Use a time limit, prioritize the safest next nursing decision, and review the reasoning after the set rather than memorizing answer letters.
Common mistakes to avoid
- Choosing a diagnosis from one symptom. A blister, ulcer, discharge, or pelvic pain is a clinical clue, not complete proof. Correct the error by combining morphology, pain pattern, associated findings, exposure history when appropriate, and the diagnostic test or specimen ordered.
- Using incubation timing as an exclusion rule. Remembering an incubation period can help organize possibilities, but patient presentation and timing are variable. Do not dismiss an STI solely because symptoms appeared earlier or later than expected; follow the assessment and testing plan.
- Stopping after the patient receives treatment. Clinical management also includes adherence, symptom follow-up, return precautions, and partner evaluation or treatment when indicated. The safety principle is to reduce ongoing infection and reinfection, not merely to document one administered therapy.
- Missing urgency in a pelvic-pain presentation. Focusing only on discharge or a named organism can delay action when fever, severe pain, pelvic tenderness, or systemic findings are present. Prioritize focused assessment, ordered testing, prescribed treatment, and escalation for deterioration.
- Leaving sexual function out of oncology care. Patients may not volunteer concerns about intimacy, body image, erection, lubrication, pain, or fertility. Use privacy, neutral language, and permission-based questions so treatment effects are identified and referred rather than silently accepted.
- Attributing every genital or urinary change to infection. A persistent ulcer, mass, unexplained bleeding, abnormal discharge, or urinary change may require oncology evaluation. The corrective cue is persistence or an atypical finding, which warrants accurate documentation and timely referral.
Try a question
A real Sexual Health, STIs, and GU Oncology question from our bank. Give it a shot.
A patient treated for gonorrhea says an asymptomatic partner does not need care. Which response by the nurse is most accurate?
Gonorrhea is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It frequently presents with minimal or no symptoms, especially in partners, contributing to ongoing transmission and complications such as pelvic inflammatory disease, infertility, and neonatal infections. Because asymptomatic individuals can still harbor and transmit the infection, public health protocols stress prompt identification, testing, and presumptive treatment of recent sexual partners to interrupt the chain of transmission.
Why the correct option is correct
Option D is correct because current guidelines recommend that all recent sexual partners of a person diagnosed with gonorrhea undergo timely evaluation and receive empiric (presumptive) treatment, regardless of symptoms. Asymptomatic carriers are significant reservoirs for transmission, and waiting for symptoms or test results in the partner can lead to ongoing spread, reinfection of the index patient, or serious complications in untreated individuals. This is supported by global and Philippine health protocols for sexually transmitted infections, which prioritize immediate partner management within the typical window of 60 days before the diagnosis.
Clinical pearl: Asymptomatic sexual partners can carry and transmit gonorrhea, so presumptive treatment significantly reduces reinfection and curtails disease spread.
Why the other options are incorrect
| Option | Why it is wrong |
|---|---|
| A | Limiting evaluation and treatment only to symptomatic partners misses most cases, as many remain asymptomatic and infectious, undermining infection control efforts. |
| B | Delaying treatment until a positive test result ignores the risk of ongoing transmission and reinfection; empiric treatment is recommended due to high rates of asymptomatic infection and diagnostic delays. |
| C | Deferring care until a follow-up or cessation of contact does not address the risk already posed; infection could persist, and the partner could remain infectious or develop complications. |
- Silvestri, L. A. (2017). Saunders Comprehensive Review for the NCLEX-RN Examination (7th ed.). Elsevier.
More Sexual Health, STIs, and GU Oncology questions
13 questions available. Sign up to practice all of them.
A gonorrhea patient completed therapy, but the untreated partner remains asymptomatic. Which counseling best explains partner care?
A sexually active adolescent has lower abdominal pain, fever, mucopurulent discharge, and cervical motion tenderness. Which interpretation best guides treatment?
An adolescent’s NAAT detects Neisseria gonorrhoeae after purulent discharge. Which interpretation should guide counseling and follow-up?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.